iPlena ^Company

What We Do. At Tegmine we target glycoproteins, which are a hallmark of numerous solid cancers and drive aggressive disease. Weve engineered a system to generate revolutionary new antibody-based therapies for cancer which dramatically increase efficacy while reducing toxic side effects.